Related Experiment Video
Updated: Jun 24, 2025

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation
Published on: September 29, 2019
Potent activity of polymyxin B is associated with long-lived super-stoichiometric accumulation mediated by
Kerry R Buchholz1, Mike Reichelt2, Matthew C Johnson3
1Department of Infectious Diseases, Genentech, Inc., South San Francisco, CA, USA. buchholz.kerry@gene.com.
Abstract:
Polymyxins are gram-negative antibiotics that target lipid A, the conserved membrane anchor of lipopolysaccharide in the outer membrane. Despite their clinical importance, the molecular mechanisms underpinning polymyxin activity remain unresolved. Here, we use surface plasmon resonance to kinetically interrogate interactions between polymyxins and lipid A and derive a phenomenological model. Our analyses suggest a lipid A-catalyzed, three-state mechanism for polymyxins: transient binding, membrane insertion, and super-stoichiometric cluster accumulation with a long residence time. Accumulation also occurs for brevicidine, another lipid A-targeting antibacterial molecule. Lipid A modifications that impart polymyxin resistance and a non-bactericidal polymyxin derivative exhibit binding that does not evolve into long-lived species. We propose that transient binding to lipid A permeabilizes the outer membrane and cluster accumulation enables the bactericidal activity of polymyxins. These findings could establish a blueprint for discovery of lipid A-targeting antibiotics and provide a generalizable approach to study interactions with the gram-negative outer membrane.
Insights
Polymyxins, crucial gram-negative antibiotics, bind lipid A in a three-state process: transient binding, insertion, and accumulation. This mechanism explains their membrane permeabilization and bactericidal activity, guiding new antibiotic discovery.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Polymyxins are vital antibiotics for treating gram-negative bacterial infections.
- Their precise molecular mechanisms of action, particularly interactions with lipid A, are not fully understood.
- Lipid A is the essential membrane anchor of lipopolysaccharide in the outer membrane of gram-negative bacteria.
Purpose of the Study:
- To elucidate the kinetic and mechanistic details of polymyxin interactions with lipid A.
- To develop a phenomenological model describing polymyxin binding and activity.
- To identify key molecular events that lead to polymyxin's bactericidal effects.
Main Methods:
- Surface plasmon resonance (SPR) was employed to kinetically analyze polymyxin-lipid A interactions.
- A phenomenological model was derived from the kinetic data.
- Interactions of brevicidine and polymyxin-resistant lipid A mutants were also studied.
Main Results:
- Polymyxins interact with lipid A via a three-state mechanism: transient binding, membrane insertion, and super-stoichiometric cluster accumulation with long residence times.
- Brevicidine, another lipid A-targeting molecule, also showed accumulation.
- Polymyxin resistance mutations and a non-bactericidal derivative impaired the transition to long-lived species.
Conclusions:
- The proposed three-state mechanism, involving transient binding for outer membrane permeabilization and cluster accumulation for bactericidal activity, explains polymyxin action.
- These findings provide a framework for designing novel lipid A-targeting antibiotics.
- The study offers a generalizable method for investigating interactions with the gram-negative outer membrane.
More Related Videos
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
10:53Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Drug Distribution: Tissue Binding
For...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...